Our global life sciences company brings diagnostic testing & drug development together. Explore what we do.
Monogram Biosciences has a legacy of developing state-of-the-art, highly reproducible, high-throughput assays in a clinical reference laboratory setting. To meet the growing demand for hepatitis C virus (HCV) assays, Monogram has developed its technology platforms to enable evaluation of HCV antiviral drug resistance and other HCV characteristics.
Please contact Monogram about technical and pricing information and validation summaries for the following assays:
Antiviral Drug Resistance